Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 29, 2024EP EuropaceOpen Access

Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: a Clinical Consensus Statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Arrhythmias are common in continuous flow LVAD patients and carry significant morbidity and mortality, yet their management differs substantially from general heart failure patients and presents unique technical challenges.

Population

Patients with continuous flow left ventricular assist devices (LVADs) and arrhythmias

Design

Clinical consensus statement

Authors

PPPetr PeichlABAntoni Bayés‐GenísTDThomas Deneke

Discussion

Loading...

Member takes

Overview

Guides arrhythmia management in LVAD patients; extends consensus strategies to a high-prevalence population with limited prior standardization.

Structured PICO

P
Population
Patients with advanced heart failure managed with continuous flow left ventricular assist devices (LVADs) who experience atrial and ventricular arrhythmias.
I
Intervention
Anti-arrhythmic drug therapy and catheter ablation

This clinical consensus statement outlines specific strategies and challenges for managing arrhythmias in LVAD patients using anti-arrhythmic drugs and catheter ablation.

Cite This Study

Peichl et al. (2024) studied this question.

synapsesocial.com/papers/69f69167e405cc4465bc2b4ahttps://doi.org/10.1093/europace/euae272
View Full Paper
Ask AI
Bookmark
Share